New York, September 25, 2013 -- Moody's Investors Service commented that Immucor, Inc.'s ("Immucor") planned repricing of its $665 million senior secured term loan due 2018 is credit positive, but does not impact its debt ratings including the B3 Corporate Family Rating or stable outlook. Moody's notes that the savings from lower interest expense per the proposed amendment should improve Immucor's cash flow slightly.

Vollständigen Artikel bei Moodys lesen